Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer

BJU International

Volumn 100, Issue 2, 2007, Pages 315-319

  Palma, David ^a   Pickles, Tom ^a   Tyldesley, Scott ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Obesity; Prostate cancer; Radiotherapy; Testosterone

Indexed keywords

TESTOSTERONE;

AGED; ARTICLE; BODY MASS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; TESTOSTERONE BLOOD LEVEL;

AGED; ANALYSIS OF VARIANCE; BODY MASS INDEX; COHORT STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBESITY; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TESTOSTERONE;

EID: 34447114696     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06897.x     Document Type: Article

References (20)

1. Belanger-Ducharme F, Tremblay A. Prevalence of obesity in Canada. Obesity Reviews 2005 6 (3 183 6
2. Bray GA. The Underlying Basis for Obesity: Relationship to Cancer. J Nutr November 1, 2002 132 (11 3451S 5
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults. N Engl J Med 2003 April 24, 2003 348 (17 1625 38
4. Freedland SJ, Aronson WJ, Kane CJ, Presti JC Jr., Amling CL, Elashoff D et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 2004 Feb 1 22 (3 446 53
5. Freedland SJ, Grubb KA, Yiu SK, Humphreys EB, Nielsen ME, Mangold LA et al. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. J Urol 2005 Sep 174 (3 919 22
6. Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC et al. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer 2006 Aug 1 107 (3 521 9
7. Strom SS, Wang X, Pettaway CA, Logothetis CJ, Yamamura Y, Do KA et al. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res 2005 Oct 1 11 (19 Pt 1 6889 94
8. Strom SS, Kamat AM, Gruschkus SK, Gu Y, Wen S, Cheung MR et al. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 2006 Aug 107 (3 631 9
9. Pickles T, Kim-Sing C, Morris WJ, Tyldesley S, Paltiel C. Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias. Int J Radiat Oncol Biol Phys 2003 Sep 57 (1 11 8
10. Roach M 3rd., Hanks G, Thames H Jr., Schellhammer P, Shipley WU, Sokol GH et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006 Jul 65 (4 965 74
11. Lukka H, Warde P, Pickles T, Morton G, Brundage M, Souhami L. Controversies in prostate cancer radiotherapy: consensus development. Can J Urol 2001 Aug 8 (4 1314 22
12. Pasquali R, Casimirri F, Cantobelli S, Melchionda N, Morselli Labate AM, Fabbri R et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991 Jan 40 (1 101 4
13. Schatzl G, Madersbacher S, Thurridl T, Waldmuller J, Kramer G, Haitel A et al. High-grade prostate cancer is associated with low serum testosterone levels. Prostate 2001 Apr 47 (1 52 8
14. Massengill JC, Sun L, Moul JW, Wu H, McLeod DG, Amling C et al. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. The Journal of urology 2003 May 169 (5 1670 5
15. Freedland SJ. Obesity and prostate cancer: a growing problem. Clin Cancer Res 2005 Oct 11 (19 Pt 1 6763 6
16. Freedland SJ, Platz EA, Presti JC Jr., Aronson WJ, Amling CL, Kane CJ et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 2006 Feb 175 (2 500 4 discussion P, Chen MH, McLeod D, Carroll PR, Moul JW, D'Amico AV. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. Journal of clinical oncology 2005 Oct 23 (28 6992 8
17. Gunnell D, Oliver SE, Peters TJ, Donovan JL, Persad R, Maynard M et al. Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer 2003 Jun 88 (11 1682 6
18. Freedland SJ, Aronson WJ. Obesity and prostate cancer. Urology 2005 Mar 65 (3 433 9
19. Amling CL. Relationship between obesity and prostate cancer. Curr Opin Urol 2005 May 15 (3 167 71
20. Presti JC Jr. Obesity and prostate cancer. Curr Opin Urol 2005 Jan 15 (1 13 6